Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Supportive care				Active				Over 18				Other				EPI-GLIO-LEV NCT00454935


2.		Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care				Active				18 and over				Other				HELLO-Study 2007 EudraCT Number: 2007-005063-96, NCT00571155

First Published: 3/4/2008


3.		Phase II Randomized Study of Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiotherapy For Primary Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				Over 18				Other				CHUV-Neurology-CePO–LEV/PGB CHUV-Neurology-CePO–LEV/PGB, EU-20807, NCT00629889

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute